US Center for Disease Control, Zika Affects 5% of Infected Babies
Five percent of women in the US territories who were infected with the Zika virus while pregnant had fetus or babies with defects, including microcephaly, government health data said Thursday.
The report by the US Centers for Disease Control and Prevention covered the US territories of Guam, American Samoa, the US Virgin Islands, Micronesia, the Republic of Marshall Islands and Puerto Rico.
The report is the first based on data from the US territories and the largest study of its kind to date.
CDC experts said the findings are consistent with previous findings about Zika cases in the mainland United States.
“Women in the US territories and elsewhere who have continued exposure to mosquitoes carrying Zika are at risk of infection,” said CDC acting director Anne Schuchat.
“We must remain vigilant and committed to preventing new Zika infections.”
The rate of birth defects was slightly higher at 8% (1-12) in women whose infections were confirmed early in the pregnancy, during the first trimester, said the report.
The findings were based on the cases of 2,549 women with possible Zika virus infection who completed their pregnancies.
Among these women, 1,508 had confirmed Zika virus infection from 1 January 2016 to 25 April 2017.
Over 120 pregnancies resulted in Zika-associated birth defects, including infants born with unusually small heads, an irreversible condition known as microcephaly.
Other complications in babies included seizures and problems with movement, coordination, eating and near constant crying.
Zika can be spread by the bite of infected mosquito or via sexual contact.
Pregnant women are urged to avoid areas of mosquito infestation where Zika is spreading.
Since Zika erupted on a large scale in mid-2015, more than 1.5-M people have been infected, mostly in Brazil and other countries in South America.
Some 70 countries have been impacted.
Zika may lead to an itchy rash and although it is dangerous for pregnant women and their fetuses, it often causes no symptoms in adults.
In November 2016, the World Health Organization (WHO) announced that the Zika virus outbreak no longer poses a world public health emergency, though it warned the epidemic remains a challenge.
In August 2016 during the height of the Zika virus panic in the US I met and spoke at length with R. Charles Murray, Founder/CEO Penta 5 USA and learned that he has succeeded in developing a new class of products that can halt a Mosquitoes appetite for human Blood.
Penta 5’s products are non-toxic and environmentally friendly. Marketed under the brand name SECURE™ no-bite the line consists of lotions and “Zone Attractants.”
The latter take the form of pouches that are filled with dry and liquid patented compounds which when combined and shaken produce a gas emission that attracts mosquitoes.
The emission confounds the mosquito’s appetite for a protein “bloodmeal” and in so doing ensures a zone of up to 400 sqf for up to 15 days.
Continual use maintains a safe no-Bite Zone. No less effective, the SECURE™ Anytime™ lotion permits users to work and play in areas outside the zone infested by “bloodmeal” seeking mosquitoes without the fear of being bitten.
Mr. Murray told me that “SECURE™ no-Bite Zone attractants have been shown to effectively reduce mosquito populations and therefor reduce the risk of dangerous bites. Also, that only the female mosquitoe seek ‘bloodmeals,’ meaning the iron and proteins of which are used to form eggs.
SECURE™ no-bite Zone 15 day emission confounds the female mosquito causing her to seek nectar as a replacement meal. Penta5’s SECURE™ Anytime™ lotion allows people to move outside of the Zone, remain bite-free and significantly, the product poses no threat to children, pets or wildlife.”
Under test in both laboratory and outdoor conditions for the past year the release of SECURE™ no-bite products now as the Zika virus breaks out over South Florida is an important safety issue for the population and the commercial interest of the State of Florida.
Penta 5 USA LLC is the wellness product division of PPi Technologies GROUP. The PPi Technologies GROUP of companies are all based in Sarasota, Florida. For more information go to: penta5usa.com/